Atlas Trials

Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients

Clinical trial NCT00819052 · COMPLETED

Trial details

NCT number
NCT00819052
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV Infections
Start date
2008-12-01
Primary completion
2012-01-01
Enrollment
445

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.